US Patent 11993625 Calicheamicin derivatives and antibody drug conjugates thereof
Patent 11993625 was granted and assigned to Pfizer on May, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 30 May, 2024
Golden AI
Edits made to:
Infobox (+23 properties)
Article (+344 characters)
US Patent 11993625 Calicheamicin derivatives and antibody drug conjugates thereof
Article
Patent abstract
The present invention is directed to novel calicheamicin derivatives useful as payloads in antibody-drug-conjugates (ADC's), and to payload-linker compounds and ADC compounds comprising the same; to pharmaceutical compositions comprising the same and to methods for using the same to treat pathological conditions such as cancer.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Chakrapani Subramanyam0
Gary Frederick Filzen0
Kenneth John Dirico0
Lawrence N. Tumey0
Omar Khaled Ahmad0
Pavel Strop0
Russell Dushin0
Stephen Paul Brown0
Sujiet Puthenveetil0
Date of Patent
May 28, 2024
0Patent Application Number
164772900
Date Filed
January 10, 2018
0Patent Citations
Patent Primary Examiner
CPC Code
Find more entities like US Patent 11993625 Calicheamicin derivatives and antibody drug conjugates thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
